1. Market Research
  2. > Pharmaceutical Market Trends
  3. > India Pharmaceutical & Healthcare Industry Report - 2016

India Pharmaceutical & Healthcare Industry Report - 2016

  • February 2016
  • -
  • Emerging Markets Direct Media Holdings
  • -
  • 35 pages

This report profiles India's pharmaceuticals and healthcare industry, discussing market trends through 2015 and outlook for 2016 and beyond. The report also highlights leading players in the sector including Dr Reddy's Laboratories Ltd, Cipla Ltd and Lupin Ltd.



Over the last decade, the Indian pharmaceutical and healthcare sector has taken great strides. India's pharmaceutical sector has achieved new heights as the world's most cost effective generic drugs manufacturer. Many Indian pharmaceutical companies have maintained the highest standards in purity, stability and international safety, health and environmental protection during the production process as well as the supply of bulk drugs. Competing fiercely with other emerging markets such as Brazil and China, India has carved a niche for itself in becoming one of the leading generic pharmaceutical manufacturers in the world.



The domestic pharmaceutical market continued on its growth trend in 2015, growing by 12% y/y. However, pharmaceuticals export growth slowed down further in the year due to the Indian rupee depreciation. Exports grew by only 4% in 2015, after experiencing double-digit growth of 11% in 2014. Going forward, a revival is expected in the sector backed by government support and various macro growth drivers, including rise in per capita income; rise in health insurance penetration; proliferation of healthcare services across remote areas; rise in lifestyle diseases; increasing preference of India as a cost effective production centre; increase in foreign investments; and increase in government and private expenditure on health. However, frequent policy changes and rising prices of raw materials may act as deterrent for growth of this sector.



Key Points:



o According to the World Health Organization, the size of India's healthcare industry was around USD 79bn as of 2013. Government accounted for around 32% of the total spending, while the private sector accounted for the remainder.



o India's pharmaceutical sector was ranked among the top five globally in terms of production volume as of 2013. However, in value term, it was minuscule in size compared to the markets of the U.S. and Japan. Indian market accounted for only 2.5% of global pharmaceutical market as of 2014.



o Exports accounted for 42% of the total size of the pharmaceutical sector as of 2015. Pharmaceutical exports thus helped in containing the country's trade deficit and added to its foreign exchange reserves.

Table Of Contents

India Pharmaceutical and Healthcare Industry Report - 2016
1. Industry Profile

1.1 Sector overview

1.2 Sector size

1.3 Competitive landscape

1.4 Environmental scanning



2. Market Trends and Outlook

2.1 Key economic indicators-India

2.2 Health status indicators

2.3 Healthcare infrastructure

2.4 Domestic pharmaceuticals market

2.5 Pharmaceuticals exports

2.6 Mergers and acquisitions

2.7 Pharmaceutical research and patents

2.8 Market outlook



3. Leading Players and Comparative Matrix

3.1 Leading players

3.1.1 Dr Reddy's Laboratories Limited (DRL)

3.1.2 Cipla Limited (Cipla)

3.1.3 Lupin Limited (Lupin)

3.2 Comparative matrix

3.3 SWOT analysis



4. Tables and Charts

Table 1: Role of the Department of Pharmaceuticals

Table 2: Responsibilities of NPPA

Table 3: Change in health infrastructure of the country

Table 4: Key financial ratios of leading players

Table 5: Latest financial results of the leading players



Chart 1: Breakup of global pharmaceutical market by region

Chart 2: Annual expenditure of Ministry of Health and Family Welfare

Chart 3: Size of Indian healthcare industry

Chart 4: Pharmaceutical exports from India

Chart 5: Estimated size of domestic pharmaceutical market

Chart 6: Market share of different players in the pharmaceutical sector of India

Chart 7: Cumulative FDI in the pharmaceutical and healthcare sector

Chart 8: Per capita expenditure on health

Chart 9: Breakup of Indian pharmaceutical market by type of drug

Chart 10: Quarterly GDP growth rate-India

Chart 11: Average monthly USD to INR exchange rate

Chart 12: Inflation-India

Chart 13: Repo rate

Chart 14: Contribution of industries in IIP by weights

Chart 15: Y/Y Change in index of industrial production

Chart 16: Child mortality rate (under 5 Years) per 1000 live births

Chart 17: Maternal mortality rate per 100,000 live births

Chart 18: Infant mortality rate (Under 1 Year) per 1000 live births

Chart 19: New HIV infections in India

Chart 20: Birth rate: India

Chart 21: Institution delivery

Chart 22: Cases of communicable diseases

Chart 23: Cases of non-communicable diseases

Chart 24: Shortage of medical professionals compared to health infrastructure

Chart 25: Segments of domestic pharmaceutical market by value

Chart 26: Market share of players in domestic pharmaceutical market by value

Chart 27: Major export destinations of Indian pharmaceuticals by value

Chart 28: Trade surplus in the pharmaceutical sector

Chart 29: Forecast for the size of Indian pharmaceutical sector

Chart 30: Breakup of company's revenue by segments (DRL)

Chart 31: Total revenues of DRL

Chart 32: Profit margin of DRL

Chart 33: Breakup of company's revenue by segments (Cipla)

Chart 34: Total revenues of Cipla

Chart 35: Profit margin of Cipla

Chart 36: Breakup of company's revenue by segments (Lupin)

Chart 37: Total revenues of Lupin

Chart 38: Profit margin of Lupin

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.